Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes

被引:39
|
作者
Yoshimatsu, Yuki [1 ,2 ]
Nakahara, Tomomi [1 ]
Tanaka, Katsuyuki [1 ]
Inagawa, Yuki [1 ]
Narisawa-Saito, Mako [1 ]
Yugawa, Takashi [1 ]
Ohno, Shin-ichi [1 ]
Fujita, Masatoshi [1 ,3 ]
Nakagama, Hitoshi [2 ,4 ]
Kiyono, Tohru [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Carcinogenesis & Canc Prevent, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan
[3] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biochem, Fukuoka, Japan
[4] Natl Canc Ctr, Tokyo, Japan
来源
CANCER SCIENCE | 2017年 / 108卷 / 07期
关键词
Cervical cancer; E6; human cervical keratinocytes; human papillomavirus; PDZ domain; HUMAN-PAPILLOMAVIRUS E6; TUMOR-SUPPRESSOR; CELL POLARITY; UBIQUITIN LIGASE; EPITHELIAL-CELLS; DEGRADATION; DOMAIN; ONCOPROTEINS; TRANSMISSION; PATHOGENESIS;
D O I
10.1111/cas.13264
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The high-risk human papillomavirus E6 proteins have been shown to interact with and lead to degradation of PDZ-domain-containing proteins through its carboxy-terminal motif. This PDZ-binding motif plays important roles in transformation of cultured cells and carcinogenesis of E6-transgenic mice. However, its biological effects on the natural host cells have not been elucidated. We have examined its roles in an in vitro carcinogenesis model for cervical cancer, in which E6 and E7 together with activated HRAS (HRAS(G12V)) can induce tumorigenic transformation of normal human cervical keratinocytes. In this model, E6151 mutant, which is defective in binding to PDZ domains, almost lost tumorigenic ability, whereas E6SAT mutant, which is defective in p53 degradation showed activity close to wild-type E6. Interestingly, we found decreased expression of PAR3 in E6-expressing cells independently of E6AP, which has not been previously recognized. Therefore, we knocked down several PDZ-domain containing proteins including PAR3 in human cervical keratinocytes expressing E7, HRAS(G12V) and E6151 to examine whether depletion of these proteins can restore the tumorigenic ability. Single knockdown of SCRIB, MAGI1 or PAR3 significantly but partially restored the tumorigenic ability. The combinatorial knockdown of SCRIB and MAGI1 cooperatively restored the tumorigenic ability, and additional depletion of PAR3 further enhanced the tumorigenic ability surpassing that induced by wild-type E6. These data highlight the importance of the carboxy-terminal motif of the E6 protein and downregulation of PAR3 in tumorigenic transformation of human cervical keratinocytes.
引用
收藏
页码:1303 / 1309
页数:7
相关论文
共 50 条
  • [41] Molecular analysis of the interaction between HPV type 16 E6 and human E6-associated protein
    Daniels, PR
    Sanders, CM
    Coulson, P
    Maitland, NJ
    FEBS LETTERS, 1997, 416 (01) : 6 - 10
  • [42] HPV-16 E6 silencing of p16INK4a in human cervical cancer cells
    Yeung, Chi Lam Au
    Tsang, Tsun Yee
    Co, Ngai Na
    Yau, Pak Lun
    Kwok, Tim Tak
    CANCER RESEARCH, 2010, 70
  • [43] Oncogenic potential of human papillomavirus E6 proteins correlates with binding affinity to PDZ domains from Mupp1
    Paduch, M.
    Mateja, A.
    Bogacz, M.
    Otlewski, J.
    FEBS JOURNAL, 2007, 274 : 176 - 176
  • [44] Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6
    Christian Kühne
    Daniela Gardiol
    Corrado Guarnaccia
    Heinz Amenitsch
    Lawrence Banks
    Oncogene, 2000, 19 : 5884 - 5891
  • [45] Differential regulation of human papillomavirus E6 by protein kinase A:: conditional degradation of human discs large protein by oncogenic E6
    Kühne, C
    Gardiol, D
    Guarnaccia, C
    Amenitsch, H
    Banks, L
    ONCOGENE, 2000, 19 (51) : 5884 - 5891
  • [46] A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors
    Wieking, B. G.
    Vermeer, D. W.
    Spanos, W. C.
    Lee, K. M.
    Vermeer, P.
    Lee, W. T.
    Xu, Y.
    Gabitzsch, E. S.
    Balcaitis, S.
    Balint, J. P., Jr.
    Jones, F. R.
    Lee, J. H.
    CANCER GENE THERAPY, 2012, 19 (10) : 667 - 674
  • [47] A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors
    B G Wieking
    D W Vermeer
    W C Spanos
    K M Lee
    P Vermeer
    W T Lee
    Y Xu
    E S Gabitzsch
    S Balcaitis
    J P Balint
    F R Jones
    J H Lee
    Cancer Gene Therapy, 2012, 19 : 667 - 674
  • [48] The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity
    Schoeman, Dewald
    Cloete, Ruben
    Fielding, Burtram C.
    VIRUSES-BASEL, 2022, 14 (08):
  • [49] The small splice variant of HPV16 E6, E6*, reduces tumor formation in cervical carcinoma xenografts
    Filippova, Maria
    Evans, Whitney
    Aragon, Robert
    Filippov, Valery
    Williams, Vonetta M.
    Hong, Linda
    Reeves, Mark E.
    Duerksen-Hughes, Penelope
    VIROLOGY, 2014, 450 : 153 - 164
  • [50] The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP
    Elston, RC
    Napthine, S
    Doorbar, J
    JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 371 - 374